Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

A new definition and treatment options of allergic alveolitis.

Author information

Affiliations

  • 1. Diagnostisk Center, Regionshospitalet Silkeborg.
      Authors
    • Østergård NM 1
    (1 author)
  • 2. Center for Sjældne Lungesygdomme, Afdeling for Lungesygdomme, Aarhus Universitetshospital.
      Authors
    • Møller J 2
    • Kronborg-White S 2
    • Prior TS 2
    • Bendstrup E 2
    (4 authors)
  • 3. Medicinsk Afdeling, Sygehus Lillebælt, Vejle.
      Authors
    • Kølner-Augustson L 3
    (1 author)
  • 4. Arbejdsmedicin, Aarhus Universitetshospital.
      Authors
    • Iversen IB 4
    • Kolstad H 4
    (2 authors)

ORCIDs linked to this article

Ugeskrift for Laeger, 01 Apr 2024, 186(14):V11230705Language:dan
https://doi.org/10.61409/v11230705 PMID: 38606704 

Review

Abstract 

In this review, we discuss a new definition and treatment options of allergic alveolitis (AA). AA is an immune-mediated interstitial lung disease triggered by inhaled antigens, it is defined as non-fibrotic (inflammatory) and/or fibrotic, and diagnosis relies on a multidisciplinary approach using clinical, radiological and sometimes histological assessments. Treatment involves early antigen elimination and may include corticosteroids or other immunosuppressants. Prognosis varies from reversible inflammation to irreversible fibrosis. Early detection is crucial for better outcomes.

Full text links 

Read article at publisher's site: https://doi.org/10.61409/v11230705

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.